MIT chemists synthesize a fungal compound that holds promise for treating brain cancer
December 3, 2025
Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells.
Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells.
Inspired by traditional acupuncture, the approach has potential to impact all implantable bioelectronic devices, enabling applications such as hypertension mitigation.
The Vanquish device’s clinical data demonstrated an elimination of MRI visible intermediate risk disease in 91% of patients after a single procedure.
ST. PAUL, Minn., Dec. 3, 2025 /PRNewswire/ — Astrin Biosciences, a cancer intelligence company transforming how cancer is detected and treated through deep proteomics and AI, announced the launch of Certitude™, the first-of-its-kind, non-imaging, blood-based early cancer detection test. Results from the latest study will be presented at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 10–14, 2025.
Two related studies published today in Nature Metabolism show that a specialized intracellular recycling mechanism—chaperone-mediated autophagy (CMA)—is essential for muscle health.
High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. A new study published in JCI Insight identifies a mechanism through which the young brain protects itself against high calcium levels, and it could help scientists learn how to protect the brain from this devastating neurodegenerative condition.
It’s not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes
Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes.
A human challenge trial has shown a new vaccine could offer better protection against whooping cough.